## Note
nid: 1520723735061
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#FirstAid::07_Cardiovascular::05_Pharm::01_Hypertension_Treatment, #AK_Step1_v11::#OME_banner::Basic_Science::09_Cardiac, #AK_Step1_v11::#Physeo::09_Pharm::10_Cardiac::01_Hypertension_Treatment, #AK_Step1_v11::#SketchyPharm::02_Cardio_&_Renal::FA-Cardio, #AK_Step1_v11::#UWorld::100-999::100-199::151, #AK_Step1_v11::#UWorld::10000-99999::15000-15999::15239, #AK_Step1_v11::^Other::^EXPN::BGadd, #AK_Step1_v11::^Other::^FA_Updates::FA2018, #AK_Step1_v11::^Other::^HighYield::3-HighYield-temporary, #AK_Step1_v11::^Systems::Cardio::Pharmacology
markdown: false

### Text
<div>
  In patients with hypertension and what comorbidity should ACE
  inhibitors / ARBs become first line?
</div>
<div>
  <div>
    {{c1::Hypertension with Diabetes Mellitus}}
  </div>
  <div><img src="paste-394570055548929.jpg"></div>
</div>

### Extra
ACE-i/ARBs are protective against diabetic nephropathy; Ca2+ channel blockers, thiazides, and Î²-blockers are good to use here as well

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy
#REF!

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org/spa/cardiac?ref=anki"><img src=
  "_OME_AnkiFlashcards_Topic_6.png"></a>
</div>

### Additional Resources


### One by one

